EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Development and validation of a liquid chromatography–tandem mass spectrometry method for the quantification of the acetyl‐coenzyme A competitive p300/CBP catalytic inhibitor A‐485 in biological samples

Reinhard Oertel iD, Nikolai Jaschke, Annemarie Lippert, Bertold Renner iD

Biomedical Chromatography · 2024

DOI: 10.1002/bmc.5819 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Reinhard Oertel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Pharmacology, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Antineoplastic Agents. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The small molecule A‐485 competitively inhibits the histone acetyltransferase domain of CBP (cyclic‐adenosine monophosphate response element‐binding protein)/p300. Apart from its antineoplastic activity, researchers are exploring its potential benefits in treating osteoporosis and its impact on energy metabolism. However, so far, only limited pharmacokinetic data are available, and the crucial determination of A‐485 concentration in various biological materials with small sample volumes remains unpublished. A rapid and sensitive LC–tandem mass spectrometry method has been developed and validated to quantify A‐485 in mouse serum and tissue. In this method, serum samples underwent precipitation with acetonitrile, while cell lysates were appropriately diluted. The determination of A‐485 utilized a reversed‐phase column with a mobile phase gradient, and detection was carried out in multiple reaction monitoring mode. The lower standard sample, with a concentration of 7.8 ng/mL, served as the lower limit of quantification, while the upper standard was established at 1000 ng/mL. A‐485 concentrations were assessed in both serum samples and the lysate of all examined tissues, revealing swift metabolic clearance. The analytical method outlined here is deemed appropriate for subsequent studies. The ability to measure the active ingredient in various compartments facilitates the determination of accurate pharmacokinetic parameters. In the event of human use of A‐485, the analysis method can be seamlessly transferred to human samples.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryAntineoplastic AgentsMiceAnimalsHumansAcetyl Coenzyme ALimit of DetectionChromatography, Liquid

Stichwörter der Autor:innen

A-485LC-MS/MSprotein precipitationserum and tissue samples

Substanzen

Acetyl Coenzyme AAntineoplastic Agents

Autor:innen und Institutionen

  • Institute of Clinical Pharmacology, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
  • Division of Endocrinology, Department of Medicine III, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.

ORCID-Profile: Reinhard Oertel, Bertold Renner

Zitieren

APA

Oertel, R., Jaschke, N., Lippert, A., & Renner, B. (2024). Development and validation of a liquid chromatography–tandem mass spectrometry method for the quantification of the acetyl‐coenzyme A competitive p300/CBP catalytic inhibitor A‐485 in biological samples. Biomedical Chromatography. https://doi.org/10.1002/bmc.5819

Vancouver

Oertel R, Jaschke N, Lippert A, Renner B. Development and validation of a liquid chromatography–tandem mass spectrometry method for the quantification of the acetyl‐coenzyme A competitive p300/CBP catalytic inhibitor A‐485 in biological samples. Biomedical Chromatography. 2024. doi:10.1002/bmc.5819

BibTeX
@article{Oertel2024,
  author = {Oertel, Reinhard and Jaschke, Nikolai and Lippert, Annemarie and Renner, Bertold},
  title = {Development and validation of a liquid chromatography–tandem mass spectrometry method for the quantification of the acetyl‐coenzyme A competitive p300/CBP catalytic inhibitor A‐485 in biological samples},
  journal = {Biomedical Chromatography},
  year = {2024},
  doi = {10.1002/bmc.5819}
}
Kostenlos starten →